Subscribe to RSS
DOI: 10.1055/s-0039-3399849
Absolute configuration of sesquiterpene lactones with potent immunosuppressant activity
Publication History
Publication Date:
20 December 2019 (online)
In a screening of Artemisia argyi (Asteraceae) and subsequent HPLC-based activity profiling canin (1) and the seco-tanapartholides 2 and 3 (stereoisomers) were identified as compounds with potent immunosuppressant activity in vitro. These isoprenoids were first discovered in 1969 and 1982, respectively, and have been extensively studied in the past for various biological activities. Although many studies have been published examining their molecular structure and relative configuration by means of NMR and X-ray [2], the absolute configuration remained unresolved. We here established the absolute configuration of compounds 1-3 by a combination of electronic circular dichroism spectroscopy (ECD) and vibrational circular dichroism spectroscopy (VCD).
ECD spectra of 1-3 were measured and compared to spectra calculated ab initio for different possible stereoisomers. The most frequently reported relative stereoisomer of canin (1) was established as (1R,2S,3R,4S,5S,6S,7S,10R)-canin. For compounds 2 and 3, the ECD data reduced the number of possible configurational isomers to four. The absolute configuration was finally established by VCD. Compound 2 was identified as (4R,5R,6S,7S)-seco-tanapartholide, and 3 as (4S,5S,6S,7S)-seco-tanapartholide. The combination of ECD and VCD is a powerful approach for resolving the absolute configuration of conformationally flexible molecules.
![](https://www.thieme-connect.de/media/plantamedica/201918/thumbnails/10.1055s-0039-3399849-f0001.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
-
References
- 1 Knight DW. Feverfew: Chemistry and Biological Activity. Nat Prod Rep. 1995: 271-275
- 2 Hewlett MJ. et al. Sesquiterpene lactones from feverfew, Tanaceturn parthenium: isolation, structural revision, activity against human blood platelet function and implications for migraine therapy. J Chem Soc, Perkin Trans 1996; 1: 1979-1986